Received Feb 4, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| TDAP | TDAP (ADACEL) | SANOFI PASTEUR | UNK | — | OT |
Injection site erythema; Injection site warmth; Initial information received on 31-Jan-2025 regarding an unsolicited valid non-serious case received from Health Authorities via Nurse. This case involves a 41 years old and unknown gender patient who experienced injection site erythema and injection site warmth after receiving Diphtheria-2/Tetanus/5 Ac Pertussis Vaccine [Adacel]. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On an unknown date, the patient received a 0.5 ml dose once of suspect Diphtheria-2/Tetanus/5 Ac Pertussis Vaccine Suspension for injection (lot number, strength and expiry not reported) via intramuscular route in unknown administration site as Immunisation. There will be no information on batch number and expiration date corresponding to the one at time of event occurrence. On an unknown date the patient developed injection site erythema and injection site warmth (unknown latency) following the administration of Diphtheria-2/Tetanus/5 Ac Pertussis Vaccine. Action taken: not applicable. It was not reported if the patient received a corrective treatment for the events. At time of reporting, the outcome was Unknown for the events.